UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - ENDOCYTE INC ownership

ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 117 filers reported holding ENDOCYTE INC in Q2 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ENDOCYTE INC
ValueSharesWeighting
Q3 2018$488,400,000
+20.0%
27,500
-6.8%
0.00%
Q2 2018$407,100,000
+262545.2%
29,500
-13.0%
0.00%
Q3 2015$155,000
-11.9%
33,8990.0%0.00%
Q2 2015$176,000
-17.0%
33,8990.0%0.00%
Q1 2015$212,000
-0.5%
33,8990.0%0.00%
Q4 2014$213,000
-97.9%
33,899
-92.2%
0.00%
-100.0%
Q1 2014$10,359,000
+70.9%
435,060
-23.3%
0.01%
+57.1%
Q4 2013$6,062,000567,0600.01%
Other shareholders
ENDOCYTE INC shareholders Q2 2018
NameSharesValueWeighting ↓
Corbenic Partners LLC 32,639$83,0000.09%
Anson Funds Management LP 108,426$276,0000.09%
Leisure Capital Management 30,038$77,0000.07%
HIGHLAND CAPITAL MANAGEMENT LP 461,561$1,177,0000.06%
Teza Capital Management LLC 14,542$37,0000.05%
PINNACLE ASSOCIATES LTD 821,543$2,095,0000.04%
Cribstone Capital Management, LLC 28,141$63,0000.04%
Curi RMB Capital, LLC 243,385$621,0000.03%
Acrospire Investment Management LLC 26,061$66,0000.03%
TWO SIGMA SECURITIES, LLC 26,758$68,0000.02%
View complete list of ENDOCYTE INC shareholders